Treatment gaps and survival outcomes of hepatocellular carcinoma: insights from a nationwide, claims-based study.

ABSTRACT:

Background

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths in Germany. National data on the management of HCC remain scarce.

Objectives

This study aims to provide an up-to-date overview of clinical characteristics, treatment modalities, and survival outcomes among patients with HCC in Germany.

Design

This is a real-world retrospective study using health insurance data from BARMER.

Methods

Patients with an HCC diagnosis between 2016 and 2020 were identified in the BARMER database. Comorbidities, anticancer therapies, and treatment pathways of those patients were evaluated using descriptive statistics and survival analysis.

Results

A total of 2778 patients with HCC were identified. Of these, 1569 (56.5%) received any anticancer t

SUBMITTER: Schrodi S 

PROVIDER: S-EPMC12547113 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature